Literature DB >> 11551945

Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2.

R Janknecht1.   

Abstract

Mitogen-activated protein kinase-activated protein kinase 2 (MK2) is an important intracellular mediator of stress signals. In this report, a novel target of MK2 has been identified, the ETS transcription factor family member ER81, whose dysregulation contributes to tumorigenesis and whose normal function is required during development. MK2 phosphorylates ER81 in vitro within its central inhibitory domain, and overexpression of MK2 leads to increased in vivo phosphorylation of ER81. Two serine residues, ER81 amino acids 191 and 216, were identified as MK2 phosphorylation sites. MK2 suppresses basal ER81-dependent transcription, and this suppressive effect is alleviated upon mutation of the MK2 phosphorylation sites in a cell type-specific manner. However, MK2 can also interfere with ER81-mediated transcription independently of serine 191 and serine 216 phosphorylation. Furthermore, MK2 overexpression counteracts the stimulation of ER81 activity by p38 mitogen-activated protein kinase. Altogether, MK2 may regulate ER81 transcriptional activity in a cell type-specific manner and thereby modulate various physiological processes beyond stress responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551945     DOI: 10.1074/jbc.M106630200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 2.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

Review 3.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

4.  Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.

Authors:  Steven M Mooney; Apollina Goel; Antonino B D'Assoro; Jeffrey L Salisbury; Ralf Janknecht
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

5.  ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Authors:  Sook Shin; Sangphil Oh; Seayoon An; Ralf Janknecht
Journal:  Oncol Rep       Date:  2012-10-16       Impact factor: 3.906

6.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.

Authors:  Basem S Goueli; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.

Authors:  Tae-Dong Kim; Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  ER81 Expression in Breast Cancers and Hyperplasia.

Authors:  Yuanyuan Wang; Li Wang; Yue Chen; Lin Li; Xuantao Yang; Baolin Li; Shuling Song; Lilin Yang; Yan Hao; Julun Yang
Journal:  Patholog Res Int       Date:  2011-02-27

10.  Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.

Authors:  Nagarathinam Selvaraj; Vivekananda Kedage; Peter C Hollenhorst
Journal:  Cell Commun Signal       Date:  2015-02-19       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.